# Valhi Inc: financial statements, quarterly

VHI · NYSE · CIK 59255 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vhi.md) · [Financials](/companies/vhi/financials.md) · [Filings](/companies/vhi/filings.md) · [Insiders](/companies/vhi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/vhi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [469](/filings/0001558370-24-014868.md) | [453 d](/filings/0001104659-26-025847.md) | [531](/filings/0001558370-25-006979.md) | [560](/filings/0001558370-25-010773.md) | [534](/filings/0001104659-25-107777.md) | [481 d](/filings/0001104659-26-025847.md) | [539](/filings/0001104659-26-057165.md) | [540](/filings/0001104659-26-092027.md) | [504](/filings/0001104659-25-107777.md) | [495 d](/filings/0001104659-26-025847.md) | [560](/filings/0001104659-26-057165.md) | [606](/filings/0001104659-26-092027.md) |
| Cost of revenue | $m | [408](/filings/0001558370-24-014868.md) | [388 d](/filings/0001104659-26-025847.md) | [444](/filings/0001558370-25-006979.md) | [438](/filings/0001558370-25-010773.md) | [417](/filings/0001104659-25-107777.md) | [380 d](/filings/0001104659-26-025847.md) | [416](/filings/0001104659-26-057165.md) | [462](/filings/0001104659-26-092027.md) | [443](/filings/0001104659-25-107777.md) | [460 d](/filings/0001104659-26-025847.md) | [457](/filings/0001104659-26-057165.md) | [486](/filings/0001104659-26-092027.md) |
| Gross profit | $m | [60.6](/filings/0001558370-24-014868.md) | [65.0 d](/filings/0001104659-26-025847.md) | [86.3](/filings/0001558370-25-006979.md) | [121](/filings/0001558370-25-010773.md) | [116](/filings/0001104659-25-107777.md) | [101 d](/filings/0001104659-26-025847.md) | [123](/filings/0001104659-26-057165.md) | [78.1](/filings/0001104659-26-092027.md) | [60.6](/filings/0001104659-25-107777.md) | [34.2 d](/filings/0001104659-26-025847.md) | [103](/filings/0001104659-26-057165.md) | [120](/filings/0001104659-26-092027.md) |
| Selling, general and administrative | $m | [69.1](/filings/0001558370-24-014868.md) | [71.1 d](/filings/0001104659-26-025847.md) | [68.6](/filings/0001558370-25-006979.md) | [74.9](/filings/0001558370-25-010773.md) | [74.2](/filings/0001104659-25-107777.md) | [38.5 d](/filings/0001104659-26-025847.md) | [78.5](/filings/0001104659-26-057165.md) | [79.2](/filings/0001104659-26-092027.md) | [77.6](/filings/0001104659-25-107777.md) | [77.0 d](/filings/0001104659-26-025847.md) | [77.5](/filings/0001104659-26-057165.md) | [78.8](/filings/0001104659-26-092027.md) |
| Operating income | $m | [2.5](/filings/0001558370-24-014868.md) | [17.2 d](/filings/0001104659-26-025847.md) | [31.5](/filings/0001558370-25-006979.md) | [54.8](/filings/0001558370-25-010773.md) | [67.7](/filings/0001104659-25-107777.md) | [56.7 d](/filings/0001104659-26-025847.md) | [50.1](/filings/0001104659-26-057165.md) | [35.5](/filings/0001104659-26-092027.md) | [8.6](/filings/0001104659-25-107777.md) | [(30.9) d](/filings/0001104659-26-025847.md) | [32.9](/filings/0001104659-26-057165.md) | [67.7](/filings/0001104659-26-092027.md) |
| Interest expense | $m | [7.2](/filings/0001558370-24-014868.md) | [6.9 d](/filings/0001104659-26-025847.md) | [11.3](/filings/0001558370-25-006979.md) | [11.9](/filings/0001558370-25-010773.md) | [13.4](/filings/0001104659-25-107777.md) | [13.3 d](/filings/0001104659-26-025847.md) | [13.2](/filings/0001104659-26-057165.md) | [13.8](/filings/0001104659-26-092027.md) | [14.9](/filings/0001104659-25-107777.md) | [15.2 d](/filings/0001104659-26-025847.md) | [14.7](/filings/0001104659-26-057165.md) | [14.7](/filings/0001104659-26-092027.md) |
| Income tax | $m | [(7.8)](/filings/0001558370-24-014868.md) | [(4.8) d](/filings/0001104659-26-025847.md) | [4.4](/filings/0001558370-25-006979.md) | [7.9](/filings/0001558370-25-010773.md) | [34.3](/filings/0001104659-25-107777.md) | [36.3 d](/filings/0001104659-26-025847.md) | [8.0](/filings/0001104659-26-057165.md) | [8.0](/filings/0001104659-26-092027.md) | [14.3](/filings/0001104659-25-107777.md) | [(18.4) d](/filings/0001104659-26-025847.md) | [6.3](/filings/0001104659-26-057165.md) | [11.8](/filings/0001104659-26-092027.md) |
| Net income | $m | [(5.8)](/filings/0001558370-24-014868.md) | [4.9 d](/filings/0001104659-26-025847.md) | [7.8](/filings/0001558370-25-006979.md) | [19.9](/filings/0001558370-25-010773.md) | [57.5](/filings/0001104659-25-107777.md) | [22.8 d](/filings/0001104659-26-025847.md) | [16.9](/filings/0001104659-26-057165.md) | [0.9](/filings/0001104659-26-092027.md) | [(22.2)](/filings/0001104659-25-107777.md) | [(53.2) d](/filings/0001104659-26-025847.md) | [2.0](/filings/0001104659-26-057165.md) | [22.3](/filings/0001104659-26-092027.md) |
| Diluted EPS | $ per share | [(0.21)](/filings/0001558370-24-014868.md) | not reported | [0.27](/filings/0001558370-25-006979.md) | [0.70](/filings/0001558370-25-010773.md) | [2.01](/filings/0001104659-25-107777.md) | not reported | [0.59](/filings/0001104659-26-057165.md) | [0.03](/filings/0001104659-26-092027.md) | [(0.78)](/filings/0001104659-25-107777.md) | not reported | [0.07](/filings/0001104659-26-057165.md) | [0.78](/filings/0001104659-26-092027.md) |
| Basic EPS | $ per share | [(0.21)](/filings/0001558370-24-014868.md) | not reported | [0.27](/filings/0001558370-25-006979.md) | [0.70](/filings/0001558370-25-010773.md) | [2.01](/filings/0001104659-25-107777.md) | not reported | [0.59](/filings/0001104659-26-057165.md) | [0.03](/filings/0001104659-26-092027.md) | [(0.78)](/filings/0001104659-25-107777.md) | not reported | [0.07](/filings/0001104659-26-057165.md) | [0.78](/filings/0001104659-26-092027.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [342](/filings/0001558370-23-017764.md) | [407](/filings/0001558370-25-002409.md) | [341](/filings/0001558370-24-007618.md) | [373](/filings/0001558370-24-011605.md) | [315](/filings/0001558370-24-014868.md) | [348](/filings/0001104659-26-025847.md) | [195](/filings/0001558370-25-006979.md) | [189](/filings/0001558370-25-010773.md) | [184](/filings/0001104659-25-107777.md) | [214](/filings/0001104659-26-092027.md) | [194](/filings/0001104659-26-057165.md) | [210](/filings/0001104659-26-092027.md) |
| Current assets | $m | [1,370](/filings/0001558370-23-017764.md) | [1,475](/filings/0001558370-25-002409.md) | [1,329](/filings/0001558370-24-007618.md) | [1,324](/filings/0001558370-24-011605.md) | [1,406](/filings/0001558370-24-014868.md) | [1,454](/filings/0001104659-26-025847.md) | [1,410](/filings/0001558370-25-006979.md) | [1,367](/filings/0001558370-25-010773.md) | [1,341](/filings/0001104659-25-107777.md) | [1,259](/filings/0001104659-26-092027.md) | [1,254](/filings/0001104659-26-057165.md) | [1,217](/filings/0001104659-26-092027.md) |
| Total assets | $m | [2,607](/filings/0001558370-23-017764.md) | [2,737](/filings/0001558370-25-002409.md) | [2,559](/filings/0001558370-24-007618.md) | [2,533](/filings/0001558370-24-011605.md) | [2,787](/filings/0001558370-24-014868.md) | [2,800](/filings/0001104659-26-025847.md) | [2,757](/filings/0001558370-25-006979.md) | [2,763](/filings/0001558370-25-010773.md) | [2,716](/filings/0001104659-25-107777.md) | [2,632](/filings/0001104659-26-092027.md) | [2,610](/filings/0001104659-26-057165.md) | [2,575](/filings/0001104659-26-092027.md) |
| Current liabilities | $m | [403](/filings/0001558370-23-017764.md) | [507](/filings/0001558370-25-002409.md) | [385](/filings/0001558370-24-007618.md) | [379](/filings/0001558370-24-011605.md) | [504](/filings/0001558370-24-014868.md) | [644](/filings/0001104659-26-025847.md) | [529](/filings/0001558370-25-006979.md) | [483](/filings/0001558370-25-010773.md) | [369](/filings/0001104659-25-107777.md) | [449](/filings/0001104659-26-092027.md) | [386](/filings/0001104659-26-057165.md) | [361](/filings/0001104659-26-092027.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [932](/filings/0001558370-23-017764.md) | [951](/filings/0001558370-25-002409.md) | [928](/filings/0001558370-24-007618.md) | [963](/filings/0001558370-24-011605.md) | [1,023](/filings/0001558370-24-014868.md) | [1,036](/filings/0001104659-26-025847.md) | [1,063](/filings/0001558370-25-006979.md) | [1,072](/filings/0001558370-25-010773.md) | [1,048](/filings/0001104659-25-107777.md) | [1,023](/filings/0001104659-26-092027.md) | [1,026](/filings/0001104659-26-057165.md) | [1,044](/filings/0001104659-26-092027.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [33.9 d](/filings/0001558370-24-014868.md) | [65.1 d](/filings/0001104659-26-025847.md) | [(48.8)](/filings/0001558370-25-006979.md) | [33.5 d](/filings/0001558370-25-010773.md) | [13.5 d](/filings/0001104659-25-107777.md) | [45.8 d](/filings/0001104659-26-025847.md) | [(156)](/filings/0001104659-26-057165.md) | [21.7 d](/filings/0001104659-26-092027.md) | [(1.9) d](/filings/0001104659-25-107777.md) | [101 d](/filings/0001104659-26-025847.md) | [(46.1)](/filings/0001104659-26-057165.md) | [59.1 d](/filings/0001104659-26-092027.md) |
| Capital expenditure | $m | [8.3 d](/filings/0001558370-24-014868.md) | [5.8 d](/filings/0001104659-26-025847.md) | [5.0](/filings/0001558370-25-006979.md) | [3.8 d](/filings/0001558370-25-010773.md) | [9.6 d](/filings/0001104659-25-107777.md) | [12.5 d](/filings/0001104659-26-025847.md) | [12.8](/filings/0001104659-26-057165.md) | [12.6 d](/filings/0001104659-26-092027.md) | [10.4 d](/filings/0001104659-25-107777.md) | [10.8 d](/filings/0001104659-26-025847.md) | [10.6](/filings/0001104659-26-057165.md) | [17.2 d](/filings/0001104659-26-092027.md) |
| Dividends paid | $m | [2.3 d](/filings/0001558370-24-014868.md) | [2.3 d](/filings/0001104659-26-025847.md) | [2.3](/filings/0001558370-25-006979.md) | [2.2 d](/filings/0001558370-25-010773.md) | [2.3 d](/filings/0001104659-25-107777.md) | [2.3 d](/filings/0001104659-26-025847.md) | [2.3](/filings/0001104659-26-057165.md) | [2.2 d](/filings/0001104659-26-092027.md) | [2.3 d](/filings/0001104659-25-107777.md) | [2.3 d](/filings/0001104659-26-025847.md) | [2.3](/filings/0001104659-26-057165.md) | [2.2 d](/filings/0001104659-26-092027.md) |
| Share repurchases | $m | [0.0 d](/filings/0001558370-24-014868.md) | [0.0 d](/filings/0001104659-26-025847.md) | [0.0](/filings/0001558370-24-007618.md) | [0.0 d](/filings/0001558370-24-011605.md) | [0.0 d](/filings/0001558370-24-014868.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [28.5](/filings/0001558370-23-017764.md) | [28.5](/filings/0001558370-24-007618.md) | [28.5](/filings/0001558370-24-011605.md) | [0.0](/filings/0001558370-24-014868.md) | [28.5](/filings/0001558370-25-006979.md) | [28.5](/filings/0001558370-25-010773.md) | [28.5](/filings/0001104659-25-107777.md) | [28.5](/filings/0001104659-26-057165.md) | [28.5](/filings/0001104659-26-092027.md) | [28.5](/filings/0001104659-25-107777.md) | [28.5](/filings/0001104659-26-057165.md) | [28.5](/filings/0001104659-26-092027.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 28,321,193 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001104659-26-092027.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.